Australia markets closed

QURE Jan 2023 7.500 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.45000.0000 (0.00%)
As of 12:04PM EDT. Market open.
Full screen
Loading interactive chart…
  • GlobeNewswire

    uniQure to Participate in Upcoming Industry Conferences in September

    LEXINGTON, Mass. and AMSTERDAM, Sept. 06, 2022 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming investor and scientific conferences: Citi’s 17th Annual BioPharma Conference, September 7 – 8, 2022 Members of uniQure’s management team, including Matt Kapusta, chief executive officer, and Ricardo Dolmetsch, Ph.D., president of research

  • Simply Wall St.

    These Analysts Just Made A Neat Downgrade To Their uniQure N.V. (NASDAQ:QURE) EPS Forecasts

    The latest analyst coverage could presage a bad day for uniQure N.V. ( NASDAQ:QURE ), with the analysts making...

  • Motley Fool

    Why uniQure Stock Is Crashing Today

    Shares of uniQure N.V. (NASDAQ: QURE) are crashing today, down by 32.6% as of 11:19 a.m. ET. The steep decline came after the gene therapy specialist provided its second-quarter update Monday morning. Investors weren't all that interested in uniQure's financial results.